6669 — Acotec Scientific Holdings Income Statement
0.000.00%
Last trade - 00:00- HK$3.95bn
- HK$3.14bn
- CNY644.63m
Annual income statement for Acotec Scientific Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 304 | 396 | 474 | 534 | 645 |
| Cost of Revenue | |||||
| Gross Profit | 266 | 336 | 377 | 403 | 476 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 367 | 323 | 449 | 470 | 511 |
| Operating Profit | -63.4 | 72.1 | 25 | 64 | 133 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -67.2 | 70.3 | 14.5 | 52.6 | 122 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -79.1 | 70.1 | 14.5 | 52.3 | 119 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -79.1 | 70.1 | 14.5 | 52.3 | 119 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -79.1 | 70.1 | 14.5 | 52.3 | 119 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.211 | 0.234 | 0.048 | 0.195 | 0.398 |